Trials / Completed
CompletedNCT02202811
Circadian Rhythms and Cardiovascular Risk
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to understand how behaviors and the effects of the body's internal clock (called the circadian pacemaker) affect the control of the heart and blood pressure. People with Obstructive Sleep Apnea (OSA) are hypothesized to have altered circadian amplitudes in certain key indices of cardiovascular (CV) and an abnormally advanced circadian phase in some of the same key indices of CV risk. The investigators hypothesize that such changes, taken together, may explain the different timing of heart attack and sudden cardiac death in OSA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Forced Desynchrony | all sleep opportunities and other activities will be scheduled by the experimenter so that by the end of the study these activities are spread evenly across all phases of the internal body clock. |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2020-03-09
- Completion
- 2020-03-09
- First posted
- 2014-07-29
- Last updated
- 2025-07-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02202811. Inclusion in this directory is not an endorsement.